Drug-Device Combination Products Consultant in Kolkata
Kolkata, located in the eastern state of West Bengal in India, is a rapidly growing hub for the medical device industry. The city is home to several established medical device manufacturers and emerging startups. With a strong focus on innovation and research, Kolkata’s medical device industry is poised for significant growth in the coming years.
Combination products are a unique category of medical products that combine two or more regulated components, including drugs, devices, and biological products. As a Drug Device Combination Products Consultant in Kolkata, we provide comprehensive guidance on combination products under 21 CFR 3.2 (e).
Types of Drug-Device Combination Products
- Pre-filled syringes
- Drug-eluting stents
- Inhalers
- Transdermal patches
- Implantable drug delivery systems
- Drug-device combination products for diagnostics
- Drug-device combination products for drug delivery systems
- Drug-device combination products for gene therapy
Drug-Device Combination Products Consultant in Kolkata?
Let’s have word about your next project
Benefits of Drug-Drug Combination Products
Despite the challenges, drug-device combination products offer many unique benefits over traditional drugs or devices alone, such as targeted therapy, improved drug delivery, and increased patient compliance. They represent an exciting and growing area of innovation in the healthcare industry, with the potential to improve patient outcomes and quality of life.
If you are looking for expert guidance in the development and regulation of drug-device combination products in Kolkata, Operon Strategist can help. Our team of experienced consultants offers a range of services. Contact us today to learn more.
FAQs
What are drug-device combination products?
Drug-device combination products are medical products that combine two or more regulated components—such as drugs, devices, or biologics—into a single integrated product regulated under 21 CFR 3.2(e).
How are combination products regulated in the US?
The FDA assigns a lead center (CDER, CDRH, or CBER) based on the Primary Mode of Action (PMOA) of the product. Regulatory requirements may include compliance with both drug and device regulations.
What are common examples of combination products?
Examples include pre-filled syringes, drug-eluting stents, inhalers, transdermal patches, implantable drug delivery systems, and certain diagnostic combination products.
What challenges do manufacturers face with combination products?
Manufacturers must address dual regulatory frameworks, quality system integration, labeling requirements, risk management, clinical evidence, and post-market compliance.
How can Operon Strategist help manufacturers in Kolkata?
Operon Strategist provides regulatory pathway determination, PMOA analysis, FDA submission support, QMS integration, documentation preparation, and strategic compliance guidance for successful product commercialization.